Introduction
Chronic kidney disease (CKD) has high prevalence and incidence worldwide, particularly in Brazil. 1 Although the National Kidney Foundation (NKF) 2 in 2002 has proposed staging CKD in order to slow the advance toward the functional failure of the kidneys, difficulties such as lack of early diagnosis, inadequate treatment in the early stages, delayed specialized monitoring, and the complexity of the disease lead many people to need renal replacement therapy (RRT). [1] [2] [3] RRT can be implemented through hemodialysis (HD), peritoneal dialysis (PD), and renal transplantation. Each treatment has its own characteristics, advantages, disadvantages, and complications. 4 Peritoneal dialysis allows the patient home treatment decreasing outpatient visits. Hemodialysis can be performed through a central catheter (CH) inserted in the internal jugular or subclavian vein or through an arteriovenous fistula (AVF) preferably in the upper limbs whose optimal functionality delay varies from one to three months. 5, 6 Nosocomial infection is one of the most serious complications and the second cause of death in dialysis patients. 7 The risk factors that predispose to nosocomial infection in RRT may be influenced by patient characteristics, site of dialysis access, and disorders of the skin and mucous membranes 8 ; and comorbidities such as diabetes mellitus, anemia, cardiovascular disease, immunosuppression, and metabolic imbalances. 4, 5 Peritonitis is the most frequent infection in patients undergoing PD, and septicemia is the most frequent complication among patients on HD, especially when conducted through a central venous catheter. The kind of vascular access for HD has significant influence on patient survival. Catheters are associated with substantially greater risk of septicemia, hospitalization, and mortality compared to AVF. 9 There are few studies in Brazil evaluating infection rates, the prevalent microorganisms and the susceptibility profile of bacterial infections associated with RRT. These data may be useful for empirical anti-infective therapy in these patients, as well as to better evaluate the choice of dialysis treatment aiming at preventing infections. The objective of the present study was to compare the prevalence of infection and related deaths, as well as the sensitivity profile of the putative bacteria in RRT treated patients.
Methods
This is a case-control study. The study sample consisted of 644 patients treated in the RRT outpatient center at Santa Casa de Misericordia de Ponta Grossa Hospital during a 29-month period. Patients on RRT who developed nosocomial infection (116 patients) were considered as cases. Patients who did not develop infection (528 patients) were considered as controls. Nosocomial infections were considered when the Commission of Hospital Infection Control (CHIC) identified the case as such, based on clinical features, complementary blood tests, and culture results of biological material. Unconfirmed cases of infection by the CHIC were excluded. The patients were divided into three groups according to the type of dialysis treatment: PD (116 patients), CH (192 patients), and arteriovenous fistula hemodialysis (AVH) (326 patients). The study was approved by the local ethics committee.
Statistical analysis
To compare categorical variables, two-tailed Fisher's exact test with Bonferroni correction for multiple comparisons was used. To evaluate the effect size Odds Ratio (OR) was calculated with 95% confidence interval (CI) and its transformation in probability (p). The samples were properly tested for normality by Anderson-Darling test. The presence of outliers was checked by the Grubbs test. The statistical power of the sample was computed in each comparison. Results are presented as mean ± standard deviation (SD). Analyses, including descriptive statistics, were performed using EPI INFO program. p < 0.05 was considered statistically significant.
Results
Of the 644 patients who underwent dialysis during the study period, 116 (18.1%) developed some infection (63 male; 57.22 ± 12.76 years). One hundred fifty-six infections were reported. Seventy-one (45.51%) infections (56.14 ± 11.22 years) were in patients on PD, 60 (38.46%) infections (59.82 ± 13.33 years) in patients on CH, and 25 (16.2%) infections in patients on AVH (53.8 ± 14.7 years) ( Table 1) .
Comparison between groups
Of the 126 patients undergoing PD, 44 (34.92%) had at least one infection during the study period, which was significantly higher than that in the other two groups (OR: 3.32; CI 95%: 2.13-5.17; p = 0.0001). CH also showed up as a risk factor for the development of infection with 48 (25%) of the 192 infected patients (OR: 1.8824; CI 95%: 1.24-2.85; p = 0.0035). The lowest incidence of infection was observed in AVH group: 24 (7.36%) of 326 patients (OR: 0.19; CI 95%: 0.12-0.35; p = 0.0001). For all comparisons made, the statistical power was greater than 99%, with a consequent error -beta less than 1% (Table 2) .
Individual comparison between groups
Comparing the groups individually, AVH turned out to be the safest method with less infections, resulting in lower incidence of morbidity when compared with CH (OR: 0.23; CI 95%: 0.14-0.40; p = 0.0001) and PD (OR: 0.14; CI 95%: 0.08-0.25; p = 0.0001). There was no statistically significant difference between the incidence of infections in the PD group and the CH group (OR: 0.62; CI 95%: 0.38-1.01; p = 0.0593). The statistical power to detect these differences was 100% in both cases, therefore no beta error (Table 3) .
Deaths
Of patients infected (116), five died due to infection, with an overall mortality rate of 4.31%. There were four deaths (9.09%) Table 6 .
Sensitivity profile of etiologic agents
The sensitivity profiles of the main isolated bacteria are shown in Table 7 . Among the most important findings, 5 (11.4%) 
Discussion
As previously reported, PD patients had higher rate of infection compared to CH and AVH patients. [9] [10] [11] [12] Likewise, a high mortality rate (9.9%) of infected patients was observed in PD 20 reported a study in which E. coli had 100% resistance to these antibiotics. An isolate of E. coli was ESBL producer (5.55%), multidrug resistant, and sensitive to meropenem. As in the study by Sader et al. 23 no resistance to this antibiotic was found in the present study. For K. pneumoniae 80% was sensitive to ceftriaxone and 60% to ceftazidime. Nogueira et al. 24 showed 53.3% and 80% sensitivity, respectively, and Almeida et al. 25 reported 34% sensitivity for both antibiotics. Serratia, Enterobacter, and Proteus were also isolated (Table 6 ). Non-fermentative bacilli were isolated in eight (5.92%) cultures, P. aeruginosa in six (4.44%) of which only one (16.7%) was multidrug resistant, and Acinetobacter baumannii was recovered in two cultures. Britta et al. 20 showed multidrug resistance in 50% of cases. Polymicrobial infections were observed in 3.5% of cases of PD group, a rate much lower than the 30%, 15 10.7%, 18 and 9.09% 25 reported by other studies. In CH group polymicrobial infections were more frequently isolated (10.71%). The lower rate of resistance of the isolates in the present study translates into reduced morbidity and hospital costs. 26 This finding could be attributed to the antimicrobial control policy implemented by the CHIC, which is based on quarterly updates of clinical sensitivity of local microbiota and prescription supervision of electronic medical records.
Conclusions
The present study provides evidence that the type of vascular access in RRT is an important predisposing factor for infection which, in turn, increases comorbidity and hospital costs. The AVF for hemodialysis is the safest access for RRT. These results emphasize the need for early referral program for patients with CKD regarding the indication and maturation of the dialysis method. This policy decreases morbidity, mortality, and hospital costs. More studies are needed, especially those that are prospective and adequately powered.
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